🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPharmacology & MechanismsGIP receptor pharmacology — January 2024 Page 3

GIP receptor pharmacology — January 2024

lisa_labSD Tue, Jan 23, 2024 at 8:49 PM 11 replies 2,054 viewsPage 3 of 3
DanielChem_CHI
Senior Member
1,234
5,678
Mar 2024
Chicago, IL
Jan 27, 2024 at 2:56 AM#11
hyun_seoul said:
The pharmacokinetics explain nearly every practical question asked here.

Agreed, and the adaptation point cuts both ways: tachyphylaxis to gastric emptying is why tolerability improves, and it is also why people who were relying on physical fullness feel the effect fade while the appetite effect is still working.

41 16fiona_VT, denise_HTX, raj_cambridge and 38 others
Reply Quote Save Share Report
EndoResFellow
Member
456
2,345
Sep 2024
Baltimore, MD
Jan 28, 2024 at 1:35 AM#12
steve_okc said:
True, though the ladder is longer and that is not a neutral detail — six dose steps means six opportunities to stall on the way up, and plenty of…

Thank you for spelling out the reasoning rather than just the conclusion. I will report back once I have actually tried it.

Last edited: Jan 28, 2024 at 3:35 AM
40 15TinaHashiRN, robert_kc, dan_philly and 37 others
Reply Quote Save Share Report
anna.melb_AU
Member
678
2,890
Apr 2024
Melbourne, AU
Jan 29, 2024 at 12:15 AM#13
hyun_seoul said:
The pharmacokinetics explain nearly every practical question asked here.

I read this differently. The confidence in this thread is running ahead of the evidence, and I would rather the uncertainty were stated than smoothed over because it is unsatisfying.

39 14emma_london, tammy_FL, Dr.LipidDallas and 36 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.GutHealth
Senior Member
1,456
7,890
Mar 2024
Minnesota
Jan 29, 2024 at 10:55 PM#14

Adding the numbers, since they settle part of this. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

Correct me if the detail matters more than I have assumed.

Last edited: Jan 30, 2024 at 3:55 AM
38 13Dr.RaviCardio, jennifer_SEA, tyler_CSCS and 35 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Jan 30, 2024 at 9:36 PM#15

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here. Carry on.

Last edited: Jan 30, 2024 at 11:36 PM
37 12PurityPaulOR, MaxMetOK, MounjBrad and 34 others
Reply Quote Save Share Report

Similar Threads

GLP-1R desensitization — β-arrestin-mediated internalization18 replies
Biased agonism at GLP-1R — Gs vs β-arrestin signaling balance13 replies
Semaglutide albumin binding and the C-18 fatty acid linker17 replies
GIP receptor pharmacology — why GIP agonism enhances GLP-113 replies
Glucagon receptor signaling — hepatic glycogenolysis and lipolysis16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register